Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

100%

8 of 8 completed trials have results

Key Signals

8 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 4

1(12.5%)

8Total

N/A(7)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05423756Not ApplicableCompleted

INSPIRE Trial for Skin and Soft Tissue Infections

Role: collaborator

NCT05423743Not ApplicableCompleted

INSPIRE Trial for Abdominal Infections

Role: collaborator

NCT03140423Phase 4Completed

Mupirocin-Iodophor ICU Decolonization Swap Out Trial

Role: collaborator

NCT03697096Not ApplicableCompleted

The INSPIRE-ASP UTI Trial

Role: collaborator

NCT03697070Not ApplicableCompleted

The INSPIRE-ASP PNA Trial

Role: collaborator

NCT04053075Not ApplicableCompleted

CLUSTER Trial for Outbreak Detection and Response

Role: collaborator

NCT02063867Not ApplicableCompleted

Active Bathing to Eliminate Infection (ABATE Infection) Trial

Role: collaborator

NCT00980980Not ApplicableCompleted

Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)

Role: collaborator

All 8 trials loaded